Carmen Bozic Vertex Pharmaceuticals Inc (VRTX) insider trading activity

Carmen Bozic is EVP and CMO of VERTEX PHARMACEUTICALS INC . Currently has a direct ownership of 32,669 shares of VRTX, which is worth approximately $14.4 Million. The most recent transaction as insider was on Feb 17, 2023, when has been sold 3,750 shares (Common Stock) at a price of $292.85 per share, resulting in proceeds of $1,098,187. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.7K

0% 3M change

8.54% 12M change

Total Value Held $14.4 Million

Carmen Bozic Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 17 2023	SELL Payment of exercise price or tax liability	$1,098,187 $292.85 p/Share	3,750 Reduced 5.34%	66,515 Common Stock
Feb 13 2023	SELL Payment of exercise price or tax liability	$1,488,913 $298.26 p/Share	4,992 Reduced 6.63%	70,265 Common Stock
Feb 10 2023	SELL Payment of exercise price or tax liability	$796,751 $294.33 p/Share	2,707 Reduced 3.47%	75,257 Common Stock
Feb 01 2023	BUY Grant, award, or other acquisition	-	28,452 Added 26.74%	77,964 Common Stock
May 31 2022	SELL Payment of exercise price or tax liability	$84,356 $271.24 p/Share	311 Reduced 0.62%	49,512 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$283,002 $227.86 p/Share	1,242 Reduced 2.43%	49,823 Common Stock
Feb 17 2022	SELL Payment of exercise price or tax liability	$799,602 $232.51 p/Share	3,439 Reduced 6.31%	51,065 Common Stock
Feb 10 2022	SELL Payment of exercise price or tax liability	$579,372 $237.74 p/Share	2,437 Reduced 4.28%	54,504 Common Stock
Feb 01 2022	BUY Grant, award, or other acquisition	-	23,988 Added 29.64%	56,941 Common Stock
May 28 2021	SELL Payment of exercise price or tax liability	$65,322 $210.04 p/Share	311 Reduced 0.93%	32,953 Common Stock
Feb 24 2021	SELL Payment of exercise price or tax liability	$67,664 $217.57 p/Share	311 Reduced 0.93%	33,264 Common Stock
Feb 10 2021	SELL Payment of exercise price or tax liability	$506,917 $214.16 p/Share	2,367 Reduced 6.59%	33,575 Common Stock
Feb 03 2021	BUY Grant, award, or other acquisition	-	21,951 Added 37.92%	35,942 Common Stock

Carmen Bozic

EVP and CMO

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Vertex Pharmaceuticals Inc insider buys or sells VRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to VERTEX PHARMACEUTICALS INC

Track Activities on VRTX

Account